- Who We Are
- Our Research Focus
JTSSF is unique in that it only funds research and programs aimed at stroke. We believe that stroke is preventable, however, scientists who seek National Institutes of Health funding for cardiovascular disease and/or stroke research receive a disproportionately small amount of NIH dollars. The NIH invests only 4 percent of its budget on heart research and a mere 1 percent on stroke research. (Obviagele, 2013).
What is needed now is to encourage novel research approaches in the field. From our perspective within clinical stroke treatment and research, we understand the importance of directing targeted research funds to the scientists and investigators who can move the best ideas in stroke research prevention and treatment forward.
The JTSSF research grant program is the heart of our commitment to preventing stroke and improving stroke treatment. Our research grant program funds investigations that advance stroke research in three key areas:
Learn more about the grants we will fund.
Ischemic stroke is defined by the deprivation of a part of the brain of blood, as when a cerebral blood vessel becomes occluded.
Hemorrhagic stroke, by contrast, constitutes the minority of strokes (15%), and is characterized by bleeding.
One common cause of a hemorrhagic stroke is a bleeding aneurysm, a weak or thin spot on an artery wall. Over time, these weak spots stretch or balloon out under high arterial pressure. The thin walls of these ballooning aneurysms can rupture and spill blood into the space surrounding brain cells.